Non-Interventional Fresh Tumor Tissue

Analysis Of Cell Count, Viability, And Of Fresh Newly Diagnosed Glioblastoma Tissue

18+

Learn more

The ImmuneSense Study

A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Phase 2b Study to Assess the Safety and Efficacy of IGV-001, an Autologous Cell Immunotherapy With Antisense Oligonucleotide (IMV-001) Targeting IGF-1R, in Newly Diagnosed Patients With Glioblastoma – The ImmuneSense Study

18-70

Learn more

Discovery

Discovery Approach to Ocular Hypertension

No minimum age

Learn more

Pistachio Intake and Macular Pigment; a Randomized Controlled Trial

Pistachios and Neural Macular Pigment; a Randomized Controlled Trial

40-70

Learn more

R33

Prospective study to validate the imaging biomarker for neuropathic corneal pain

18+

Learn more

NASA

Neurosensory Abnormalities in SymptomAtic Ocular Surface Patients (NASA)

21+

Learn more

PreDICT

Predicting the Success of Dry Eye Disease Treatment Using Hyperosmolarity Drops

18+

Learn more

DEcIDED

Intracanalicular Dexamethasone Insert for the Treatment of Inflammation and Discomfort in Dry Eye Disease

18+

Learn more

Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma

A Phase II/III Randomized Study of R-MiniCHOP With or Without CC-486 (Oral Azacitidine) in Participants Age 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma, Grade IIIB Follicular Lymphoma, Transformed Lymphoma, and High-Grade B-Cell Lymphomas With MYC AND BCL2 and/or BCL6 (S1918)

75+

Learn more

Letermovir for secondary prophylaxis for CMV disease in solid organ transplant recipients

A pilot trial of the tolerability and clinical effectiveness of letermovir when used for secondary prophylaxis to prevent recurrent cytomegalovirus disease in solid organ transplant recipients

18-75

Learn more